EUVIMEDEUVIMED entdecken
Open Access

Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab

Christopher Willy Schwarz, Mads Kirchheiner Rasmussen, Trine Bertelsen, Lars Iversen, Lone Skov, Nikolai Loft

JAMA Dermatology · 01.12.2025 · 161 (12) · 1289

DOI: 10.1001/jamadermatol.2025.3928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.12.2025. Verfasst von Christopher Willy Schwarz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cohort study estimates 5-year standardized risks for any first cancer among patients being treated with biologics for moderate to severe psoriasis.

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Copenhagen, Denmark.
  • Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Health Institute, Aarhus University, Aarhus, Denmark.

Zitieren

APA

Schwarz, C. W., Rasmussen, M. K., Bertelsen, T., Iversen, L., Skov, L., & Loft, N. (2025). Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab. JAMA Dermatology, 161(12), 1289. https://doi.org/10.1001/jamadermatol.2025.3928

Vancouver

Schwarz CW, Rasmussen MK, Bertelsen T, Iversen L, Skov L, Loft N. Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab. JAMA Dermatology. 2025;161(12):1289. doi:10.1001/jamadermatol.2025.3928

BibTeX
@article{Schwarz2025,
  author = {Schwarz, Christopher Willy and Rasmussen, Mads Kirchheiner and Bertelsen, Trine and Iversen, Lars and Skov, Lone and Loft, Nikolai},
  title = {Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab},
  journal = {JAMA Dermatology},
  year = {2025},
  volume = {161},
  number = {12},
  pages = {1289},
  doi = {10.1001/jamadermatol.2025.3928}
}
Kostenlos starten →